Recent studies have shown that olfactomedin Like 3 (OLFML3) exhibits an anti-glioma effect by regulating GAMs infiltration under the influence of the biological clock, and a positive correlation between the survival of GBM patients and the expression level of OLFML3 has been reported (147). The gene discussed is OLFML3; the disease is central nervous system cancer.